NewAmsterdam Pharma Company NV Live Stock Price Today, Share Analysis and Chart

Name: NewAmsterdam Pharma Company NV: Is Infosys Ltd. worth buying?
Item: NewAmsterdam Pharma Company NV
Rating: 1.78941675
Author: Trendlyne DVM scores

about

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, i...

36.76 -0.29 (-0.78%)

161.45% Gain from 52W Low

883.5K

XNAS Volume

XNAS 07 Nov, 2025 4:30 PM (EST)

Board Meeting

The next board meeting for NewAmsterdam Pharma Company NV is on 12 Nov 2025 for the purpose of Stifel Healthcare Conference 2025 See details

Not Eligible

Expensive Valuation

5.2 / 100

Technically Moderately Bullish

66.4 / 100

1Yr Price target upside is 22%

13 analysts

NewAmsterdam Pharma Company NV Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

NewAmsterdam Pharma Company NV Live Stock Price Today, Share Analysis and Chart

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, i...

161.45% Gain from 52W Low

SWOT Analysis

NewAmsterdam Pharma Company NV Live Price Chart